CD41+ microparticles and sGPVI levels in rheumatoid arthritis patients
| Parameters . | Rheumatoid arthritis (n = 10) . | Healthy controls (n = 10) . | P . |
|---|---|---|---|
| Platelet count (×106/L) | |||
| Median | 250 | 297 | NS |
| Range | 178-306 | 143-350 | |
| CD41+ microparticles (×106/L) | |||
| Median | 1372 | 164 | <.01 |
| Range | 619-7325 | 33-295 | |
| CLEC-2 on CD41+ microparticles (ratio MFI over isotype) | |||
| Median | 1.6 | 1.7 | NS |
| Range | 1.4-2.2 | 1.4-2.2 | |
| GPVI on CD41+ microparticles (ratio MFI over isotype) | |||
| Median | 1.6 | 2.2 | <.01 |
| Range | 1.3-1.8 | 1.8-2.7 | |
| sGPVI (ng/mL) | |||
| Median | 27 | 8 | <.01 |
| Range | 14-50 | 6-17 |
| Parameters . | Rheumatoid arthritis (n = 10) . | Healthy controls (n = 10) . | P . |
|---|---|---|---|
| Platelet count (×106/L) | |||
| Median | 250 | 297 | NS |
| Range | 178-306 | 143-350 | |
| CD41+ microparticles (×106/L) | |||
| Median | 1372 | 164 | <.01 |
| Range | 619-7325 | 33-295 | |
| CLEC-2 on CD41+ microparticles (ratio MFI over isotype) | |||
| Median | 1.6 | 1.7 | NS |
| Range | 1.4-2.2 | 1.4-2.2 | |
| GPVI on CD41+ microparticles (ratio MFI over isotype) | |||
| Median | 1.6 | 2.2 | <.01 |
| Range | 1.3-1.8 | 1.8-2.7 | |
| sGPVI (ng/mL) | |||
| Median | 27 | 8 | <.01 |
| Range | 14-50 | 6-17 |
NS, not significant.